Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. Drug safety is an important aspect of pharmacovigilance that focuses on ensuring that drugs are safe for use by patients. Pharmacovigilance and drug safety are critical components of healthcare systems around the world. They help to ensure that drugs are safe and effective for patients and can help to prevent adverse drug reactions. Advancements in pharmacovigilance and drug safety include new technologies for monitoring adverse events, improved reporting systems for adverse drug reactions, and new regulations for drug safety.

Artificial Intelligence (AI): AI is being used in pharmacovigilance to analyse large amounts of data and identify potential adverse drug reactions. This allows for faster and more accurate detection of safety issues.

Electronic Health Records (EHRs): EHRs are being used to collect and analyze data on drug safety. This allows for more comprehensive and accurate reporting of adverse drug reactions.

Mobile Health (mHealth): mHealth technology is being used to monitor patients and collect data on drug safety in real time. This allows for faster detection of safety issues and more personalized treatment plans.

Regulatory Harmonization: Regulatory harmonization is the process of aligning regulatory requirements across different countries and regions. This allows for more efficient and effective drug safety monitoring and reporting.

Patient Involvement: Patients are encouraged to report adverse drug reactions and participate in drug safety monitoring. This allows for a more comprehensive understanding of drug safety issues and helps to ensure that patient safety is a top priority.